Walleye Capital LLC Cullinan Oncology, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 156,497 shares of CGEM stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,497
Previous 328,417
52.35%
Holding current value
$1.33 Million
Previous $5.5 Million
65.33%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CGEM
# of Institutions
153Shares Held
67.1MCall Options Held
41.1KPut Options Held
112K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$64.9 Million13.93% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$48.8 Million2.62% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$30.1 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$29 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$28.7 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $387M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...